Cyclic neutropenia in mammals

Jorge M. Pacheco, Arne Traulsen, Tibor Antal, David M Dingli

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

Cyclic neutropenia (CN) has been well documented in humans and the gray collie. A recent model of the architecture and dynamics of hematopoiesis has been used to provide insights into the mechanism of cycling of this disorder. It provides a link between the cycling period and the cells where the mutated ELA2 is expressed. Assuming that the biologic defect in CN is the same in dogs, and the observation that the structure of hematopoiesis is invariant across mammals, we use allometric scaling techniques to correctly predict the period of cycling in the gray collie and extend it to other mammals from mice to elephants. This work provides additional support for the relevance of animal models to understand disease but cautions that disease dynamics in model animals are different and this has to be taken into consideration when planning experiments.

Original languageEnglish (US)
Pages (from-to)920-921
Number of pages2
JournalAmerican Journal of Hematology
Volume83
Issue number12
DOIs
StatePublished - Dec 2008

Fingerprint

Hematopoiesis
Mammals
Animal Models
Dogs
Cyclic neutropenia

ASJC Scopus subject areas

  • Hematology

Cite this

Cyclic neutropenia in mammals. / Pacheco, Jorge M.; Traulsen, Arne; Antal, Tibor; Dingli, David M.

In: American Journal of Hematology, Vol. 83, No. 12, 12.2008, p. 920-921.

Research output: Contribution to journalArticle

Pacheco, JM, Traulsen, A, Antal, T & Dingli, DM 2008, 'Cyclic neutropenia in mammals', American Journal of Hematology, vol. 83, no. 12, pp. 920-921. https://doi.org/10.1002/ajh.21295
Pacheco, Jorge M. ; Traulsen, Arne ; Antal, Tibor ; Dingli, David M. / Cyclic neutropenia in mammals. In: American Journal of Hematology. 2008 ; Vol. 83, No. 12. pp. 920-921.
@article{d82a84e84a794bda8ac6673b9e47d6c9,
title = "Cyclic neutropenia in mammals",
abstract = "Cyclic neutropenia (CN) has been well documented in humans and the gray collie. A recent model of the architecture and dynamics of hematopoiesis has been used to provide insights into the mechanism of cycling of this disorder. It provides a link between the cycling period and the cells where the mutated ELA2 is expressed. Assuming that the biologic defect in CN is the same in dogs, and the observation that the structure of hematopoiesis is invariant across mammals, we use allometric scaling techniques to correctly predict the period of cycling in the gray collie and extend it to other mammals from mice to elephants. This work provides additional support for the relevance of animal models to understand disease but cautions that disease dynamics in model animals are different and this has to be taken into consideration when planning experiments.",
author = "Pacheco, {Jorge M.} and Arne Traulsen and Tibor Antal and Dingli, {David M}",
year = "2008",
month = "12",
doi = "10.1002/ajh.21295",
language = "English (US)",
volume = "83",
pages = "920--921",
journal = "American Journal of Hematology",
issn = "0361-8609",
publisher = "Wiley-Liss Inc.",
number = "12",

}

TY - JOUR

T1 - Cyclic neutropenia in mammals

AU - Pacheco, Jorge M.

AU - Traulsen, Arne

AU - Antal, Tibor

AU - Dingli, David M

PY - 2008/12

Y1 - 2008/12

N2 - Cyclic neutropenia (CN) has been well documented in humans and the gray collie. A recent model of the architecture and dynamics of hematopoiesis has been used to provide insights into the mechanism of cycling of this disorder. It provides a link between the cycling period and the cells where the mutated ELA2 is expressed. Assuming that the biologic defect in CN is the same in dogs, and the observation that the structure of hematopoiesis is invariant across mammals, we use allometric scaling techniques to correctly predict the period of cycling in the gray collie and extend it to other mammals from mice to elephants. This work provides additional support for the relevance of animal models to understand disease but cautions that disease dynamics in model animals are different and this has to be taken into consideration when planning experiments.

AB - Cyclic neutropenia (CN) has been well documented in humans and the gray collie. A recent model of the architecture and dynamics of hematopoiesis has been used to provide insights into the mechanism of cycling of this disorder. It provides a link between the cycling period and the cells where the mutated ELA2 is expressed. Assuming that the biologic defect in CN is the same in dogs, and the observation that the structure of hematopoiesis is invariant across mammals, we use allometric scaling techniques to correctly predict the period of cycling in the gray collie and extend it to other mammals from mice to elephants. This work provides additional support for the relevance of animal models to understand disease but cautions that disease dynamics in model animals are different and this has to be taken into consideration when planning experiments.

UR - http://www.scopus.com/inward/record.url?scp=56749134176&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=56749134176&partnerID=8YFLogxK

U2 - 10.1002/ajh.21295

DO - 10.1002/ajh.21295

M3 - Article

C2 - 18951469

AN - SCOPUS:56749134176

VL - 83

SP - 920

EP - 921

JO - American Journal of Hematology

JF - American Journal of Hematology

SN - 0361-8609

IS - 12

ER -